Vanillin (3-methoxy-4-hydroxybenzaldehyde) inhibits mutation induced by hydrogen peroxide, N-methyl-N-nitrasoguanidine and mitomycin C but not Cs-137gamma-radiation at the CD59 locus in human-hamster hybrid A(L) cells
Dl. Gustafson et al., Vanillin (3-methoxy-4-hydroxybenzaldehyde) inhibits mutation induced by hydrogen peroxide, N-methyl-N-nitrasoguanidine and mitomycin C but not Cs-137gamma-radiation at the CD59 locus in human-hamster hybrid A(L) cells, MUTAGENESIS, 15(3), 2000, pp. 207-213
We have investigated the ability of the naturally occurring plant essence v
anillin (3-methoxy-4-hydroxybenzaldehyde) to inhibit mutation at the CD59 l
ocus on human chromosome 11 by hydrogen peroxide, N-methyl-N-nitrosoguanidi
ne, mitomycin C and Cs-137 gamma-radiation in human-hamster hybrid AL cells
. Previous studies using vanillin have suggested that it can inhibit chromo
some aberrations induced by hydrogen peroxide and mitomycin C, as well as i
nhibiting X-ray- and UV-induced mutations at the hprt locus. Other studies
with vanillin have shown that it can increase both the toxicity and mutagen
icity of ethyl methane sulfonate and increase the induction of sister chrom
atid exchange by mitomycin C and a variety of other mutagens, The increased
sensitivity of the AL assay, which is due in part to its ability to detect
both small (single locus) and large (multilocus) genetic damage, allows us
to measure the effect of vanillin at low doses of mutagen. Vanillin is sho
wn, in these studies, to inhibit mutation induced by hydrogen peroxide, N-m
ethyl-N-nitrosoguanidine and mitomycin C, as well as to enhance the toxicit
y of these agents. Vanillin had no effect on either toxicity or mutation in
duced by Cs-137 gamma-radiation. The vanillin-induced potentiation of H2O2
toxicity is shown not to involve inhibition of catalase or glutathione pero
xidase, These results show that vanillin is able to inhibit mutation at the
CD59 locus and modify toxicity in a mutagen-specific manner. Possible mech
anisms to explain the action of vanillin include inhibition of a DNA repair
process that leads to the death of potential mutants or enhancement of DNA
repair pathways that protect from mutation but create lethal DNA lesions d
uring the repair process.